Results for tag: "Anti Senescence Drug"

The Anti Senescence Drug market within the context of Central Nervous System Drugs is a rapidly growing sector of the pharmaceutical industry. These drugs are designed to slow or reverse the effects of aging on the brain and nervous system. They are used to treat age-related cognitive decline, dementia, Alzheimer's disease, Parkinson's disease, and other neurological disorders. These drugs are typically administered orally or intravenously, and may be combined with other treatments such as physical therapy and lifestyle modifications. The Anti Senescence Drug market is driven by an aging population, increasing awareness of age-related cognitive decline, and the development of new treatments. The market is expected to continue to grow as more treatments become available and the demand for these drugs increases. Some companies in the Anti Senescence Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more